Test d'un cCapteur de mesure du temps de pâturage et de rumination sur des vaches laitières au pâturage

peer reviewedUse of automated tools on farms is increasing worldwide and there are diverse applications available including optimization of grazing through monitoring rumination and ingestion times. The objective of this study was to evaluate the accuracy of the sensor developed by Medria to estimate grazing (G) and rumination (Ru) on pasture. This sensor includes a tri-axial accelerometer and provides data every 5 minutes. The trial lasted 12 days on 12 grazing cows in the CTA (Belgium), representing 380 h of observations. The data registered by the Medria device (M) were compared with visual observation (VO). The datasets were compared using Fleiss-κ estimating the concordance of 5-min observations and linear regression analysis was used to estimate the Pearson correlation coefficients (rp) and relative prediction error (RPE). Moderate for G (κ=0.502) and poor agreement for Ru (κ=0.175) were observed. Linear relationship between VO and M was highlighted with rp: 0.793; P<0.001 for G and rp=0.32; P<0.05 for Ru. The relative error prediction was 0.16 and 0.44 for G and Ru respectively. With regards to these results, reliable data about grazing are provided on a daily basis. The reliability of rumination data was poor

Effet de la permission de traite sur la circulation et la production laitère de vaches traites par un robot de traite au pâturage

peer reviewedIn dairy farms automatic milking systems and grazing, traffic to the robot is the cornerstone of profitability as higher milking frequency enhances milk yield. In this study, we investigated whether shortening the minimum milking interval (MMI), i.e., the required time between two milkings for an animal to get access to the milking unit, coupled with high concentrate allocation, could increase the daily milking frequency (MF, milking/cow/day) and consequently the milk yield of grazing cows. Two groups of cows (n = 19 and n = 20) belonging to the same herd were discriminated based on concentrate supply (high vs. low: 4 vs. 2 kg/cow/day) and then further divided on the basis of MMI (4 h vs. 6 h) so that four groups were formed (HC4 h–HC6 h–LC4 h and finally LC6 h). Higher concentrate allocation induced a rise in milk yield (MY, kg/cow/day) and allowed to stabilize it in periods of grass shortage but did not influence milking frequency, while shorter MMI (4 h) was correlated with higher MF without effect on MY. A combination of both strategies (4 h and high concentrate) improved the traffic globally to the robot. This result was linked to a reduction of refused milking and, therefore, the decrease in returns to the robot. This strategy could be advised to maximize the system’s efficiency during periods of high milk sales. When the economic conditions do not favour the increase in concentrate supply, short MMI could facilitate the traffic and increase the efficiency of returns.Autograssmilk - Innovative and sustainable systems combining automatic milking and precision grazin

Studies on hemostasis in COVID-19 deserve careful reporting of the laboratory methods, their significance and their limitations

We read with much interest the recent observational study of Nougier et al., which aimed at studying thrombin generation (TG) and fibrinolysis profiles of COVID-19 patients admitted to an intensive care unit (ICU) or to an internal medicine ward and receiving various schemes of prophylactic heparin.[1] They reported that thrombin potential remained within normal range despite heparin and that fibrinolysis was decreased in relation with increased plasminogen activator inhibitor 1 (PAI-1) and thrombin-activatable fibrinolysis inhibitor (TAFI) antigen plasma levels. Using the rotational thromboelastometry (ROTEM) delta device with EXTEM reagents and the addition of 0.625µg/mL tPA (referred to as 'TEM-tPA'), they reported decreased clot lysis in COVID-19 patients, which was more pronounced in patients who presented a thrombotic event, compared to event-free patients

Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians

Click to hear Dr Baglin's perspective on the role of the laboratory in treatment with new oral anticoagulants SUMMARY: One of the key benefits of the direct oral anticoagulants (DOACs) is that they do not require routine laboratory monitoring. Nevertheless, assessment of DOAC exposure and anticoagulant effects may become useful in various clinical scenarios. The five approved DOACs (apixaban, betrixaban, dabigatran etexilate, edoxaban and rivaroxaban) have different characteristics impacting assay selection and the interpretation of results. This article provides an updated overview on (i) which test to use (and their advantages and limitations), (ii) when to assay DOAC levels, (iii) how to interpret the results relating to bleeding risk, emergency situations and perioperative management, and (iv) what is the impact of DOACs on routine and specialized coagulation assays. Assays for anti-Xa or anti-IIa activity are the preferred methods when quantitative information is useful, although the situations in which to test for DOAC levels are still debated. Different reagent sensitivities and variabilities in laboratory calibrations impact assay results. International calibration standards for all specific tests for each DOAC are needed to reduce the inter-laboratory variability and allow inter-study comparisons. The impact of the DOACs on hemostasis testing may cause false-positive or false-negative results; however, these can be minimized by using specific assays and collecting blood samples at trough concentrations. Finally, prospective clinical trials are needed to validate the safety and efficacy of proposed laboratory thresholds in relation to clinical decisions. We offer recommendations on the tests to use for measuring DOACs and practical guidance on laboratory testing to help patient management and avoid diagnostic errors. ispartof: Journal of Thrombosis and Haemostasis vol:16 issue:2 pages:209-219 ispartof: location:England status: publishe